LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2025 Results on September 4, 2025
LifeVantage (Nasdaq:LFVN), a health and wellness company focused on cellular-level health products, has scheduled its fourth quarter and full fiscal year 2025 financial results announcement for September 4, 2025, after market close.
The company will host a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time). U.S. participants can dial (877) 704-4453, while international callers should use (201) 389-0920. A replay will be available until September 18, 2025. A live webcast will be accessible through the company's Investor Relations website, with a 30-day archive period.
LifeVantage (Nasdaq:LFVN), azienda nel settore salute e benessere specializzata in prodotti per la salute a livello cellulare, ha fissato la pubblicazione dei risultati finanziari del quarto trimestre e dell’intero esercizio fiscale 2025 per il 4 settembre 2025, dopo la chiusura dei mercati.
La società terrà una conference call per gli investitori alle 14:30 Mountain Time (16:30 Eastern Time). I partecipanti negli USA possono chiamare il numero (877) 704-4453; per le chiamate internazionali il numero è (201) 389-0920. La registrazione sarà disponibile fino al 18 settembre 2025. La diretta streaming sarà accessibile tramite il sito Investor Relations della società e resterà archiviata per 30 giorni.
LifeVantage (Nasdaq:LFVN), una compañía de salud y bienestar centrada en productos para la salud a nivel celular, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año fiscal completo 2025 para el 4 de septiembre de 2025, después del cierre del mercado.
La compañía celebrará una conferencia telefónica para inversores a las 14:30 hora de la montaña (16:30 hora del Este). Los participantes en EE. UU. pueden marcar (877) 704-4453; los llamantes internacionales deben usar (201) 389-0920. Habrá una repetición disponible hasta el 18 de septiembre de 2025. Una transmisión en vivo estará accesible a través del sitio web de Relaciones con Inversores de la compañía y permanecerá archivada durante 30 días.
LifeVantage (Nasdaq:LFVN), 세포 수준의 건강 제품에 주력하는 건강·웰니스 기업이 2025 회계연도 4분기 및 연간 실적 발표를 2025년 9월 4일 시장 마감 후로 예정했습니다.
회사 측은 투자자 대상 컨퍼런스 콜을 오후 2시 30분 마운틴타임(동부시간 오후 4시 30분)에 진행합니다. 미국 참여자는 (877) 704-4453으로, 해외에서 걸 경우에는 (201) 389-0920을 이용하십시오. 녹음 재청취는 2025년 9월 18일까지 가능합니다. 생중계는 회사 투자자 관계 웹사이트를 통해 제공되며 30일간 아카이브됩니다.
LifeVantage (Nasdaq:LFVN), entreprise de santé et bien‑être axée sur des produits favorisant la santé au niveau cellulaire, a prévu d’annoncer ses résultats financiers du quatrième trimestre et de l’exercice 2025 le 4 septembre 2025, après la clôture des marchés.
La société tiendra une conférence téléphonique pour les investisseurs à 14h30 Mountain Time (16h30 Eastern Time). Les participants aux États‑Unis peuvent composer le (877) 704‑4453 ; les appelants internationaux doivent utiliser le (201) 389‑0920. La rediffusion sera disponible jusqu’au 18 septembre 2025. Un webcast en direct sera accessible via le site Relations Investisseurs de la société et restera archivé pendant 30 jours.
LifeVantage (Nasdaq:LFVN), ein Gesundheits- und Wellnessunternehmen mit Fokus auf zellbasierte Gesundheitsprodukte, hat die Veröffentlichung der Finanzergebnisse für das vierte Quartal und das gesamte Geschäftsjahr 2025 für den 4. September 2025 nach Börsenschluss geplant.
Das Unternehmen veranstaltet um 14:30 Mountain Time (16:30 Eastern Time) eine Telefonkonferenz für Investoren. Teilnehmer aus den USA wählen (877) 704-4453, internationale Anrufer nutzen (201) 389-0920. Eine Aufzeichnung ist bis zum 18. September 2025 verfügbar. Ein Live-Webcast ist über die Investor-Relations-Website des Unternehmens zugänglich und wird 30 Tage archiviert.
- None.
- None.
SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2025, after the stock market closes on Thursday, September 4, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, September 18, 2025, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13755010, or (412) 317-6671 from international locations, and entering confirmation code 13755010.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1727833&tp_key=a40e7ecfbe. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When will LifeVantage (LFVN) release Q4 and fiscal year 2025 earnings?
How can investors join the LifeVantage (LFVN) Q4 2025 earnings call?
What is the replay information for LifeVantage's Q4 2025 earnings call?
Where can I access the webcast of LifeVantage's Q4 2025 earnings call?
